Event-Related potential markers of brain changes in preclinical familial Alzheimer disease

Neurology

Volumn 77, Issue 5, 2011, Pages 469-475

  Quiroz, Y T ^a,b   Ally, B A ^c   Celone, K ^a   McKeever, J ^d,e   Ruiz Rizzo, A L ^b   Lopera, F ^b   Stern, C E ^a   Budson, A E ^d,e  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c VANDERBILT UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESENILIN 1;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN; CLINICAL ARTICLE; COLOMBIA; CONTROLLED STUDY; DISEASE COURSE; EVENT RELATED POTENTIAL; FAMILIAL DISEASE; FEMALE; FRONTAL LOBE; GENE MUTATION; HETEROZYGOTE; HUMAN; MALE; NEUROPHYSIOLOGY; OCCIPITAL LOBE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SIBLING; VISUAL MEMORY;

EID: 80051511249     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318227b1b0     Document Type: Article

References (36)

1. Zhou Y, Dougherty JH Jr, Hubner KF, Bai B, Cannon RL, Hutson RK. Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment. Alzheimers Dement 2008; 4:265-270. (Pubitemid 351866121)
2. Papaliagkas V, Kimiskidis V, Tsolaki M, Anogianakis G. Usefulness of event-related potentials in the assessment of mild cognitive impairment. BMC Neurosci 2008;9:107.
3. Raggi A, Consonni M, Iannaccone S, et al. Auditory eventrelated potentials in non-demented patients with sporadic amyotrophic lateral sclerosis. Clin Neurophysiol 2008; 119:342-350. (Pubitemid 350297143)
4. Bennys K, Portet F, Touchon J, Rondouin G. Diagnostic value of event-related evoked potentials N200 and P300 subcomponents in early diagnosis of Alzheimer's disease and mild cognitive impairment. J Clin Neurophysiol 2007;24:405-412. (Pubitemid 47524880)
5. Bokura H, Yamaguchi S, Kobayashi S. Event-related potentials for response inhibition in Parkinson's disease. Neuropsychologia 2005;43:967-975. (Pubitemid 40248904)
6. Ally BA, Waring JD, Beth EH, McKeever JD, Milberg WP, Budson AE. Aging memory for pictures: using highdensity event-related potentials to understand the effect of aging on the picture superiority effect. Neuropsychologia 2008;46:679-689. (Pubitemid 351186560)
7. Ally BA, McKeever JD, Waring JD, Budson AE. Preserved frontal memorial processing for pictures in patients with mild cognitive impairment. Neuropsychologia 2009;47: 2044-2055.
8. Golob EJ, Ringman JM, Irimajiri R, et al. Cortical eventrelated potentials in preclinical familial Alzheimer disease. Neurology 2009;73:1649-1655.
9. Bobes MA, Garcia YF, Lopera F, et al. ERP generator anomalies in presymptomatic carriers of the Alzheimer's disease E280A PS-1 mutation. Hum Brain Mapp 2010;31: 247-265.
10. Olichney JM, Iragui VJ, Salmon DP, Riggins BR, Morris SK, Kutas M. Absent event-related potential (ERP) word repetition effects in mild Alzheimer's disease. Clin Neurophysiol 2006;117:1319-1330. (Pubitemid 43825778)
11. Missonnier P, Gold G, Fazio-Costa L, et al. Early eventrelated potential changes during working memory activation predict rapid decline in mild cognitive impairment. J Gerontol A Biol Sci Med Sci 2005;60:660-666. (Pubitemid 40847936)
12. Katada E, Sato K, Ojika K, Ueda R. Cognitive eventrelated potentials: useful clinical information in Alzheimer's disease. Curr Alzheimer Res 2004;1:63-69.
13. Husain MM, Trevino K, Siddique H, McClintock SM. Present and prospective clinical therapeutic regimens for Alzheimer's disease. Neuropsychiatr Dis Treat 2008;4: 765-777.
14. Reiman EM, Langbaum JB, Tariot PN. Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible. Biomark Med 2010;4:3-14.
15. Lleo A, Berezovska O, Growdon JH, Hyman BT. Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations. Am J Geriatr Psychiatry 2004;12:146-156. (Pubitemid 38250298)
16. Rosselli MC, Ardila AC, Moreno SC, et al. Cognitive decline in patients with familial Alzheimer's disease associated with E280a presenilin-1 mutation: a longitudinal study. J Clin Exp Neuropsychol 2000;22:483-495.
17. Ardila A, Lopera F, Rosselli M, et al. Neuropsychological profile of a large kindred with familial Alzheimer's disease caused by the E280A single presenilin-1 mutation. Arch Clin Neuropsychol 2000;15:515-528. (Pubitemid 30609705)
18. Gomez-Isla T, Wasco W, Pettingell WP, et al. A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes. Ann Neurol 1997;41:809-813. (Pubitemid 27249187)
19. Lopera F, Ardilla A, Martinez A, et al. Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 1997;277:793-799. (Pubitemid 27111314)
20. Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 2002;99:4703-4707. (Pubitemid 34286048)
21. Schott JM, Fox NC, Frost C, et al. Assessing the onset of structural change in familial Alzheimer's disease. Ann Neurol 2003;53:181-188. (Pubitemid 36163999)
22. Johnson KA, Lopera F, Jones K, et al. Presenilin-1- associated abnormalities in regional cerebral perfusion. Neurology 2001;56:1545-1551. (Pubitemid 32532268)
23. Mondadori CR, Buchmann A, Mustovic H, et al. Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Brain 2006;129:2908-2922. (Pubitemid 44684512)
24. Quiroz YT, Budson AE, Celone K, et al. Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease. Ann Neurol 2010;68:865-875.
25. Ringman JM, O'Neill J, Geschwind D, et al. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain 2007;130:1767-1776. (Pubitemid 47343801)
26. Aguirre-Acevedo DC, Gomez RD, Moreno S, et al. [Validity and reliability of the CERAD-Col neuropsychological battery.] Rev Neurol 2007;45:655-660. (Pubitemid 350292863)
27. Ally BA, Budson AE. The worth of pictures: using high density event-related potentials to understand the memorial power of pictures and the dynamics of recognition memory. Neuroimage 2007;35:378-395. (Pubitemid 46240932)
28. Cronin-Golomb A, Gilmore GC, Neargarder S, Morrison SR, Laudate TM. Enhanced stimulus strength improves visual cognition in aging and Alzheimer's disease. Cortex 2007;43:952-966. (Pubitemid 47520455)
29. Trollor JN, Sachdev PS, Haindl W, Brodaty H, Wen W, Walker BM. A high-resolution single photon emission computed tomography study of verbal recognition memory in Alzheimer's disease. Dement Geriatr Cogn Disord 2006;21:267-274.
30. Cummings JL. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol Aging 2000;21:845-861.
31. McKee AC, Au R, Cabral HJ, et al. Visual association pathology in preclinical Alzheimer disease. J Neuropathol Exp Neurol 2006;65:621-630. (Pubitemid 44288946)
32. Chetelat G, Villemagne VL, Bourgeat P, et al. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol 2010;67:317-324.
33. McEvoy LK, Fennema-Notestine C, Roddey JC, et al. Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology 2009;251:195-205.
34. Sluimer JD, van der Flier WM, Karas GB, et al. Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease. Eur Radiol 2009;19:2826-2833.
35. Karas G, Sluimer J, Goekoop R, et al. Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. AJNR Am J Neuroradiol 2008;29:944-949. (Pubitemid 351684972)
36. Chapman RM, Nowlis GH, McCrary JW, et al. Brain event-related potentials: diagnosing early-stage Alzheimer's disease. Neurobiol Aging 2007;28:194-201. (Pubitemid 44894631)